PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Garz, A.-K.* ; Habringer, S.* ; Wolf, S.* ; Vick, B. ; Weickert, M.-T.* ; Jeremias, I. ; Spiekermann, K.* ; Peschel, C.* ; Oostendorp, R.A.J.* ; Keller, U.* ; Goetze, K.S.*

Azacitidine in combination with the selective FLT3 kinase inhibitor crenolanib effectively disrupts stromal protection of CD34+Leukemia-Initiating Cells (LIC) in FLT3-ITD+ Acute Myeloid Leukemia (AML).

Blood 126 (2015)
Open Access Green as soon as Postprint is submitted to ZB.
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language english
Publication Year 2015
HGF-reported in Year 0
ISSN (print) / ISBN 0006-4971
e-ISSN 1528-0020
Journal Blood
Quellenangaben Volume: 126, Issue: 23 Pages: , Article Number: , Supplement: ,
Publisher American Society of Hematology
Publishing Place Washington
Reviewing status Peer reviewed
Institute(s) Research Unit Gene Vector (AGV)
CCG Pathogenesis of Acute Myeloid Leukemia (KKG-KPL)
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s) Immune Response and Infection
PSP Element(s) G-501590-001
G-521000-001
WOS ID WOS:000368019002113
Erfassungsdatum 2016-03-11
[➜Report correction]